Development of a collagen calcium-phosphate scaffold as a novel bone graft substitute. by Al-Munajjed, Amir A et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Anatomy Articles Department of Anatomy
1-1-2008
Development of a collagen calcium-phosphate
scaffold as a novel bone graft substitute.
Amir A. Al-Munajjed
Royal College of Surgeons in Ireland
John P. Gleeson
Royal College of Surgeons in Ireland
Fergal J. O'Brien
Royal College of Surgeons in Ireland, fjobrien@rcsi.ie
This Article is brought to you for free and open access by the Department
of Anatomy at e-publications@RCSI. It has been accepted for inclusion in
Anatomy Articles by an authorized administrator of e-publications@RCSI.
For more information, please contact epubs@rcsi.ie.
Citation
Al-Munajjed A, Gleeson JP, O'Brien FJ. Development of a collagen calcium-phosphate scaffold as a novel bone graft substitute. Stud
Health Technol Inform. 2008; 133:11-20.
— Use Licence —
Attribution-Non-Commercial-ShareAlike 1.0
You are free:
• to copy, distribute, display, and perform the work.
• to make derivative works.
Under the following conditions:
• Attribution — You must give the original author credit.
• Non-Commercial — You may not use this work for commercial purposes.
• Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only
under a licence identical to this one.
For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these
conditions can be waived if you get permission from the author.
Your fair use and other rights are in no way affected by the above.
This work is licenced under the Creative Commons Attribution-Non-Commercial-ShareAlike License. To
view a copy of this licence, visit:
URL (human-readable summary):
• http://creativecommons.org/licenses/by-nc-sa/1.0/
URL (legal code):
• http://creativecommons.org/worldwide/uk/translated-license
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/anatart/27
DEVELOPMENT OF A COLLAGEN
CALCIUM-PHOSPHATE SCAFFOLD
AS A NOVEL BONE GRAFT
SUBSTITUTE
Amir A. AL-MUNAJJED a,b,1, John P. GLEESON a,b and Fergal J. O’BRIEN a,b
aRoyal College of Surgeons in Ireland, Department of Anatomy, Ireland
bTrinity College Dublin, Trinity Centre of Bioengineering, Ireland
Abstract. Previous investigations have shown that collagen shows excellent bio-
logical performance as a scaffold for tissue engineering. As a primary constituent of
bone and cartilage, it demonstrates excellent cell adhesion and proliferation. How-
ever, in bone tissue engineering, it has insufficient mechanical properties for im-
plantation in a load-bearing defect. The objective of this preliminary study was to
investigate the possibility of developing a collagen/calcium-phosphate composite
scaffold which would combine the biological performance and the high porosity
of a collagen scaffold with the high mechanical stiffness of a calcium-phosphate
scaffold.
Collagen scaffolds were produced by a lyophilisation process from a collagen
slurry. The scaffolds were soaked for different exposure times in solutions of 0.1 M,
0.5 M or 1.0 M NaNH4HPO4 followed by 0.1 M, 0.5 M or 1.0 M CaCl2. Mechan-
ical tests of each scaffold were performed on a uniaxial testing system. Young‘s
moduli were determined from stress-strain curves. The pore structure and porosity
of the scaffolds were investigated using micro-computed tomography. A pure col-
lagen scaffold served as a control.
All scaffolds showed a significantly increased compressive stiffness relative to the
pure collagen scaffolds. The exposure to the 0.5 M solutions showed significantly
superior results compared to the other groups. Analysis of the pore structure indi-
cated a decrease in the overall porosity of the composite scaffolds relative to the
controls. Regarding mechanical stiffness and porosity, scaffolds after 1 hour expo-
sure to the 0.5 M solutions showed the best properties for bone tissue engineering.
Further work will involve producing a scaffold with a more homogeneous calcium
phosphate distribution.
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1. Introduction
Every year, up to 4 million bone replacement procedures are performed worldwide which
require the use of either a bone graft or bone graft substitute. The most common situation
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is whereby bone is taken from the patient‘s own body and re-implanted, namely an auto-
graft. However, there is a limited amount of bone which can be removed from a particu-
lar donor site and extra invasive surgery needs to be performed. Another option is the use
of an allograft whereby bone is removed from an organ donor. The drawbacks with this
approach include a risk of infectious disease being transmitted and fewer growth factors
present to stimulate the growth of new bone as the graft does not contain any living cells.
Recently the focus has changed to bone tissue engineering.
Scaffolds in tissue engineering must ensure a sufficient porosity and permeability to al-
low ingrowth of host tissue and nutrient flow through the tissue [1]. The scaffold also
requires adequate mechanical integrity to withstand both the implantation procedure and
the mechanical forces when implanted in load-baring areas [1, 2 & 3]. Hydroxyapatite
and Calcium-Phosphate (CP) scaffolds are commonly used in bone tissue engineering
because of their high mechanical stiffness and biocompatibility. However, the rigidity,
brittleness and poor resorbability of ceramics have restricted their use in this area. Cur-
rently, no final consensus has been reached concerning the question of which substitute
graft material might be the best for clinical application [1, 2]. Previous investigations in
our laboratory have shown that scaffolds fabricated from collagen, a normal constituent
of bone and cartilage, show excellent biological performance, promoting cell adhesion
and growth due to their high porosity of 99.5% [4, 5 & 6]. However, they have insuf-
ficient mechanical properties for bone tissue engineering. Scaffolds based on CP show
excellent mechanical stability for implantation in a load-bearing defect [7, 8]. Therefore
combining both materials might produce a scaffold with the optimal properties for bone
tissue engineering.
The objective of this preliminary study was to investigate the possibility of developing
a collagen/CP composite scaffold by coating collagen scaffolds with CP. The specific
goals were (1) to improve the mechanical stiffness of pure collagen scaffolds and (2) to
maintain the high porosity and permeability of the composite scaffolds in comparison to
the pure collagen scaffolds.
2. Material and Methods
2.1. Fabrication of pure collagen scaffolds
Pure collagen scaffolds were fabricated from a collagen suspension using a freeze dry-
ing method that has been previously described [4, 5 & 9]. Briefly, the suspension was
produced from microfibrillar type I collagen, isolated from bovine tendon (Integra Life-
Sciences, Plainsboro, NJ, USA) and mixed at 15,000 rpm in an overhead blender (IKA
Works, Inc., Wilmington, NC, USA). To prevent denaturation of the collagen fibres, the
temperature of the suspension was held at 4oC using a cooling system during the blending
procedure (Lauda, Westbury, NY, USA). The slurry was poured into a stainless steel tray
which was placed into a freeze-dryer (VirTis Co., Gardiner, NY, USA) at room temper-
ature. The temperature was then lowered at a constant cooling rate of 0.9o C/min to the
final temperature. The influence of varying freeze-drying temperatures on the pore size
of the scaffolds has been previously described [4]. Consequently, a final freeze-drying
temperature of -40oC was used to produce scaffolds with a mean pore size of approx-
imately 95 µm [5]. The shelf and chamber temperature were then held constant at the
final temperature for 60 minutes to complete the freezing process. The shelf temperature
was then ramped up to 0oC for 160 minutes. The ice phase was then sublimated under a
vacuum of approximately 200 mTorr at 0oC for 17 hours to produce the porous collagen
scaffold.
2.2. Calcium phosphate coating
Calcium chloride (CaCl2) and ammonium sodium hydrogen phosphate (NaNH4HPO4)
(Sigma Aldrich, Germany) solutions were prepared by mixing in Tris buffer at a pH of
7.4 (50 mM Tris, 1% NaN3) according to Yaylaoglu et al.[10]. Three concentrations of
each solution were prepared (0.1, 0.5 and 1.0 M). A preliminary investigation showed
that a significantly superior CP coating resulted using a process when starting with an
initial exposure to NaNH4HPO4, followed by a second exposure to CaCl2 and repeating
these steps [11]. Consequently this treatment was also chosen in this study. Each scaffold
was immersed first in the phosphate solution, followed by the calcium chloride solution.
This process was then repeated, as seen in Table 1. The influence of the exposure dura-
tion was also investigated by using a short exposure of 1 h and a long exposure of 22 h.
Thus, in this study three different concentrations, as well as two different exposure times
were compared, resulting in six scaffolds (A - F) as demonstrated in Table 1.
Table 1. Explanation of the durations and concentrations for the calcium phosphate coating on the collagen
scaffolds.
Exposure 1st Exposure 2nd Exposure 3rd Exposure 4th Exposure
NaNH4HPO4 CaCl2 NaNH4HPO4 CaCl2
Scaffold type
(Duration) Concentration Concentration Concentration Concentration
A (1 h) 0.1 M 0.1 M 0.1 M 0.1 M
B (22 h) 0.1 M 0.1 M 0.1 M 0.1 M
C (1 h) 0.5 M 0.5 M 0.5 M 0.5 M
D (22 h) 0.5 M 0.5 M 0.5 M 0.5 M
E (1 h) 1.0 M 1.0 M 1.0 M 1.0 M
F (22 h) 1.0 M 1.0 M 1.0 M 1.0 M
2.3. Mechanical testing
Mechanical characterisation of the scaffolds (n=6) was performed on a uniaxial testing
system (Zwick Z005 with a 5 N load cell). Compression tests were performed at room
temperature in a water bath after immersion in phosphate buffered saline. Young‘s mod-
uli were determined between strains of 2 and 5% by finding the slope of the interpolated
stress-strain curve. Statistical analysis was performed using one-way ANOVA tests from
SPSS with the Tukey Post Hoc test. The level for significance was chosen as p < 0.05.
2.4. Micro-computed tomography
The three-dimensional structure of the scaffolds (n=2) was analyzed using micro-
computed tomography (µ-CT). Scans were performed on a Scanco Medical 40 Micro-
CT system (Bassersdorf, Switzerland) with 70 kVP X-ray source and 112 µA. Morpho-
logical calculations were carried out on the reconstructed sections using the standard
Scanco software package to calculate the porosity from the total number of voxels.
3. Results
3.1. Mechanical testing
The compressive moduli of the different scaffold variants are shown in Figure 1. All
composite scaffolds showed a significantly increased compressive stiffness relative to the
pure collagen scaffolds (0.3 kPa) due to the addition of the CP phase.
Increasing the exposure times from 1 to 22 h showed no significant difference between
the 0.1 M and the 1.0 M solution treatments. However, a trend of increased stiffness
could be seen. This trend was significant for the 0.5 M solutions comparing scaffold C
(1 h) and D (22 h).
The scaffolds after the treatment with the 0.5 M solutions showed significantly higher
moduli compared to all other groups. In particular, the scaffolds produced after 22 h
exposure to the 0.5 M solutions showed the highest compressive moduli.
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Figure 1. Compressive moduli of pure collagen scaffolds and composite scaffolds after exposure to 0.1 M, 0.5
M and 1.0 M solutions for 1 and 22 h.
3.2. Micro-computed tomography
2D images obtained of the scaffolds using µ-CT show the effect of the different coating
treatments (Figure 2, 3 & 4). White areas represent CP, while black areas show regions
where no CP is present. All scaffolds showed a CP coating on the collagen struts.
Figure 2. 2D µ-CT slices of Scaffold A (1 h) and B (22 h) after coating with 0.1 M phosphate and calcium
solutions.
Figure 2 demonstrates the results of the coating treatments with the 0.1 M concentra-
tions (Scaffold A and B). Both scaffolds show a relatively homogeneous CP distribution.
No clear difference is observed between A and B. This is consistent with the mechanical
test data.
Figure 3. 2D µ-CT slices of Scaffold C (1 h) and D (22 h) after coating with 0.5 M phosphate and calcium
solutions.
Figure 3 demonstrates the results of the coating treatments with the 0.5 M concen-
trations (Scaffold C and D). Both scaffolds showed a more heterogeneous distribution of
CP in comparison to Figure 2. Scaffold C had a very homogeneous CP structure in the
central area, while in the outer area some concentrated CP amounts can be seen. Scaffold
D shows greater levels of localised CP clusters throughout the sample.
Figure 4. 2D µ-CT slices of Scaffold E (1 h) and F (22 h) after coating with 1.0 M phosphate and calcium
solutions.
Figure 4 demonstrates the results of the coating treatments with the 1.0 M concentra-
tions (Scaffold E and F). Scaffold E shows a very heterogeneous CP distribution through-
out. In particular high levels of CP clusters were observed in the circumference. Scaf-
fold F however, showed a homogeneous CP distribution in the central area, and small
concentrated CP amounts in the outer area.
The overall scaffold porosity as well as the porosity in the outer surface and in the
central area of the scaffolds are shown in Table 2.
Scaffold types that had been treated with the 0.1 M solution (Scaffolds A and B) had the
highest overall porosity. Scaffold D, coated for 22 h in the 0.5 M solutions showed the
lowest overall porosity.
Table 2. Preliminary results of the overall, central and surface porosity of the collagen scaffolds after exposure
to 0.1 M, 0.5 M and 1.0 M solutions for 1 and 22 h (n=2).
Porosity
Duration 0.1 M Concentration 0.5 M Concentration 1.0 M Concentration
A C E
overall 59 ± 1 % 49 ± 0 % 18 ± 4 %
1 h centre 80 ± 2 % 80 ± 4 % 31 ± 6 %
surface 52 ± 7 % 22 ± 9 % 10 ± 5 %
B D F
overall 63 ± 5 % 13 ± 4 % 36 ± 6 %
22 h centre 81 ± 6 % 43 ± 11 % 51 ± 16 %
surface 51 ± 10 % 5 ± 3 % 15 ± 7 %
4. Discussion
Bone tissue engineering has had limited clinical success to date. In order for a scaffold
to be successful in bone tissue engineering, a trade-off between mechanical properties
and porosity is required. For implantation in load-bearing areas, mechanical stability is
essential, as well as a high porosity and permeability to facilitate nutrient flow through
the scaffold [1, 12]. The objective of this study was to investigate the possibility of devel-
oping a collagen/calcium-phosphate composite scaffold by coating a collagen scaffold
with CP. The results indicate a significant increase in the mechanical properties of the
scaffolds, although a reduction in porosity was observed relative to the control scaffold.
CP could be detected using µ-CT in all scaffolds after coating.
The treatments using the lowest concentration (0.1 M) showed the lowest increase in me-
chanical properties. However, compared with pure collagen scaffolds, this increase was
significant. The overall, central and surface porosity was the highest in this embodiment
compared to all other composite scaffolds. Furthermore, the distribution of the CP was
homogeneous (Figure 2).
Scaffolds that were treated with 0.5 M solutions showed the highest compressive moduli,
although the overall porosity was decreased. The scaffolds after the 1 h exposure main-
tained a relatively high porosity, in particular in the central area. After 22 h of exposure
to the 0.5 M solutions, a large reduction in porosity was observed. In particular the scaf-
folds possessed a dense outer surface of CP. This treatment therefore seems inadvisable
for bone tissue engineering by reducing the ability of the scaffold to satisfactorily pro-
mote cellular penetration.
This investigation indicated that using 1.0 M concentrations leads to higher compressive
moduli compared to the pure collagen scaffold, but the reduction in porosity results in
a scaffold unsuitable for tissue engineering. This reduction in porosity is insufficient for
seeding the scaffolds with cells, as well as limiting nutrient flow throughout the scaffold.
The results from this preliminary investigation indicate that the recommended treatment
for CP coatings is 1 h exposure to the 0.5 M phosphate and the 0.5 M calcium chloride
solution. Although a reduced porosity was observed, the magnitude of the decrease in
porosity was lower than in the other groups making this coating technique superior to
the other treatments. However, further work is necessary to obtain a more homogeneous
CP distribution throughout the scaffolds as well as an increased porosity. This may be
realised by increasing the pore size of the collagen scaffolds prior to coating using tech-
niques that are well established in our laboratory [4, 5]. Furthermore, the influence of CP
coating on cellular activity needs to be investigated by analysing the biological compati-
bility, specifically cell adhesion and proliferation.
With a similar CP process and commercially available Gelfix scaffolds, Yaylaoglu et al.,
Kose et al. and Du et al. showed similar results of increased mechanical properties [9,
13 & 14]. However no data on the mechanical properties of these scaffolds is available.
Using scaffolds with a initial porosity of 60 %, a final porosity of 50 % was achieved
after their CP treatment. The best scaffold from our preliminary investigation (Scaffold
C) showed an overall porosity of 50 % and in the central area more than 80 % indicating
the potential of these first generation collagen/calcium-phosphate composite scaffolds
for bone tissue engineering applications.
5. Conclusion
This preliminary investigation has successfully developed a composite scaffold by coat-
ing pure collagen scaffolds with calcium-phosphate. While a reduction of 50 % in the
porosity of the scaffolds was obtained, an increase of almost 7000 % in the mechanical
properties of the scaffolds was found indicating the potential of the scaffold for future
studies.
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